Cargando…
Comprehensive Analysis of Transcriptomics and Genetic Alterations Identifies Potential Mechanisms Underlying Anthracycline Therapy Resistance in Breast Cancer
Anthracycline is a mainstay of treatment for breast cancer patients because of its antitumor activity. However, anthracycline resistance is a critical barrier in treating breast cancer. Thus, it is of great importance to uncover the molecular mechanisms underlying anthracycline resistance in breast...
Autores principales: | Liu, Zihao, Gao, Jingbo, Gu, Ran, Shi, Yu, Hu, Hong, Liu, Jianlan, Huang, Jiefeng, Zhong, Caineng, Zhou, Wenbin, Yang, Yaping, Gong, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775906/ https://www.ncbi.nlm.nih.gov/pubmed/36551262 http://dx.doi.org/10.3390/biom12121834 |
Ejemplares similares
-
Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity
por: Ding, Yonghe, et al.
Publicado: (2022) -
Genetics of Anthracycline-Associated Cardiotoxicity
por: Al-Otaibi, Talal Khalid, et al.
Publicado: (2022) -
Intermediate molecular phenotypes to identify genetic markers of anthracycline-induced cardiotoxicity risk
por: Gómez-Vecino, Aurora, et al.
Publicado: (2023) -
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
por: Gómez-Vecino, Aurora, et al.
Publicado: (2023) -
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)